|
Volumn 13, Issue 5, 2005, Pages 518-519
|
The 'pro-sense' approach to Duchenne muscular dystrophy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
DRUG CARRIER;
DYSTROPHIN;
F 127;
MESSENGER RNA;
NUCLEASE;
PARVOVIRUS VECTOR;
POLOXAMER;
RIBONUCLEASE H;
SMALL NUCLEAR RIBONUCLEOPROTEIN;
UNCLASSIFIED DRUG;
SMALL NUCLEAR RNA;
3' UNTRANSLATED REGION;
5' UNTRANSLATED REGION;
ADENO ASSOCIATED VIRUS;
BECKER MUSCULAR DYSTROPHY;
CELL REGENERATION;
CHEMICAL MODIFICATION;
DETERIORATION;
DISEASE COURSE;
DISEASE SEVERITY;
DUCHENNE MUSCULAR DYSTROPHY;
ENHANCER REGION;
EXON;
FRAMESHIFT MUTATION;
GENE MUTATION;
GENE THERAPY;
HUMAN;
MOUSE STRAIN;
MUSCLE CELL;
MUSCLE CONTRACTILITY;
MUSCLE FUNCTION;
MUSCLE POTENTIAL;
MUTAGENESIS;
NONHUMAN;
NOTE;
NUCLEOTIDE SEQUENCE;
OPEN READING FRAME;
PLASMID;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN DEFICIENCY;
PROTEIN EXPRESSION;
PROTEIN LOCALIZATION;
RISK FACTOR;
RNA SPLICING;
ANIMAL;
ARTICLE;
BIOSYNTHESIS;
GENE REPRESSION;
GENETICS;
MOUSE;
ADENO-ASSOCIATED VIRUS;
PARVOVIRUS;
ANIMALS;
DYSTROPHIN;
EXONS;
GENE THERAPY;
HUMANS;
MICE;
MUSCULAR DYSTROPHY, DUCHENNE;
OLIGORIBONUCLEOTIDES, ANTISENSE;
RNA, SMALL NUCLEAR;
SUPPRESSION, GENETIC;
|
EID: 18844442551
PISSN: 10184813
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.ejhg.5201381 Document Type: Note |
Times cited : (12)
|
References (7)
|